NCT01373138View on ClinicalTrials.gov

Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

May 31, 2006

Conditions
Healthy
Interventions
DRUG

Desloratadine and pseudoephedrine

Desloratadine and pseudoephedrine 5/240 mg

Trial Locations (1)

G1V 2K8

SFBC Anapharm, Sainte-Foy (Quebec)

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY